ZA202109079B - Β-ketosulfoxide derivative for carboxylic acid drugs as well as preparation method and application thereof - Google Patents
Β-ketosulfoxide derivative for carboxylic acid drugs as well as preparation method and application thereofInfo
- Publication number
- ZA202109079B ZA202109079B ZA2021/09079A ZA202109079A ZA202109079B ZA 202109079 B ZA202109079 B ZA 202109079B ZA 2021/09079 A ZA2021/09079 A ZA 2021/09079A ZA 202109079 A ZA202109079 A ZA 202109079A ZA 202109079 B ZA202109079 B ZA 202109079B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- well
- application
- carboxylic acid
- acid drugs
- Prior art date
Links
- 150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011530930.XA CN112939828A (en) | 2020-12-22 | 2020-12-22 | Beta-ketone sulfoxide derivative of carboxylic acid drugs and preparation method and application thereof |
CN202110923842.4A CN113501773B (en) | 2020-12-22 | 2021-08-12 | Beta-ketone sulfoxide derivative of carboxylic acid drugs and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA202109079B true ZA202109079B (en) | 2022-02-23 |
Family
ID=76234823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2021/09079A ZA202109079B (en) | 2020-12-22 | 2021-11-15 | Β-ketosulfoxide derivative for carboxylic acid drugs as well as preparation method and application thereof |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN112939828A (en) |
ZA (1) | ZA202109079B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112939828A (en) * | 2020-12-22 | 2021-06-11 | 宁夏大学 | Beta-ketone sulfoxide derivative of carboxylic acid drugs and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862214A (en) * | 1973-05-14 | 1975-01-21 | Warner Lambert Co | 2-hydroxy-2-(methylsulfonyl)-acetophenone acetates and related compounds |
CN110981844A (en) * | 2019-12-19 | 2020-04-10 | 江南大学 | Preparation method of sulfoxide flavonoid and sulfone flavonoid |
CN111646941A (en) * | 2020-07-17 | 2020-09-11 | 天津科技大学 | Sulfonamide derivative and preparation method and application thereof |
CN112939828A (en) * | 2020-12-22 | 2021-06-11 | 宁夏大学 | Beta-ketone sulfoxide derivative of carboxylic acid drugs and preparation method and application thereof |
-
2020
- 2020-12-22 CN CN202011530930.XA patent/CN112939828A/en active Pending
-
2021
- 2021-08-12 CN CN202110923842.4A patent/CN113501773B/en active Active
- 2021-11-15 ZA ZA2021/09079A patent/ZA202109079B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN112939828A (en) | 2021-06-11 |
CN113501773B (en) | 2022-07-01 |
CN113501773A (en) | 2021-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018001491A (en) | Methods for preparation of bile acids and derivatives thereof. | |
ZA201201791B (en) | Method for the preparation of 2,5-furandicarboxylic acid and esters thereof | |
EP3943491A4 (en) | Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component | |
EP2564847A4 (en) | Pharmaceutical composition for improving solubility of prasugrel and its preparation method | |
ZA202306105B (en) | Heart-nourishing and nerve-soothing pharmaceutical composition and method for preparation thereof and application thereof | |
ZA202106803B (en) | Quinoline carboxylic acid ester compound and preparation method and use thereof | |
WO2011127290A3 (en) | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
EP2311498A4 (en) | External preparation comprising fatty acid salt or benzoic acid salt of basic pharmacologically active component, and method for production thereof | |
MA43066A (en) | Methods for preparation of bile acids and derivatives thereof | |
EA032951B1 (en) | Glutarimide derivative, use thereof, pharmaceutical composition based thereon, process for preparing same | |
HK1205118A1 (en) | Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof | |
WO2011152809A3 (en) | Effervescent formulations comprising cephalosporin and clavulanic acid | |
ZA202109079B (en) | Β-ketosulfoxide derivative for carboxylic acid drugs as well as preparation method and application thereof | |
EP3248981A4 (en) | C14-hydroxyl esterified amino acid derivatives of triptolide, and preparation method and use thereof | |
WO2012019428A8 (en) | Benzohydrol derivatives, a preparation process and pharmaceutical use thereof | |
EP2321421A4 (en) | Process for preparation of mycophenolic acid, its salt and ester derivatives | |
WO2016091805A3 (en) | Naloxone monopreparation and multi-layer tablet | |
EP3680227A4 (en) | Method for preparing substituted phenylacetic acid derivative | |
EP3828196A4 (en) | Method for preparing antibody-drug conjugate intermediate by means of acid method and application thereof | |
PL3960240T3 (en) | Pharmaceutical preparation and method for producing same | |
EP3996727A4 (en) | Method for gut mucosa preparation to enhance microbial engraftment | |
EP3960164A4 (en) | Method for producing pharmaceutical formulation | |
EP3256455B8 (en) | Method for the reduction of carboxylic acids or carbonic acid and their derivatives | |
IL270970A (en) | Method for producing 3-arylpropionamide compound and 3-arylpropionic acid ester compound | |
HUE060351T2 (en) | Method for the preparation of aminobenzoic acid or an aminobenzoic acid derivative |